Company record
LEO PHARMA INC
0 FDA warning letters since 2023 and 1 recall in the last 12 months.
Get an email the day FDA posts anything new about LEO PHARMA INC.
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Mar 4 | Class II | LEO PHARMA INC Drug |
Adbry, (tralokinumab-ldrm) injection, 300 mg/2mL, Packaged as a) 1 x Single dose Autoinjector, SAMPLE NOT FOR SALE, NDC 50222-350-91; b) 2 x Single dose Autoinjectors, NDC 50222-350-02; Rx only, Manufactured by: LEO Pha… Lack of Assurance of Sterility: due to the presence of particulate matter in one unit from the lot, which lab tests have identified as wool fiber. FDA notice D-0339-2026 |